Liquid Biopsy May Identify NSCLC Patients Who Will Benefit from Radiation
A novel liquid biopsy test may determine which patients with NSCLC that has spread beyond the lungs will benefit from high-dose radiation.
Read MorePosted by Andy Lundin | Oct 2, 2023 | Lung Cancer |
A novel liquid biopsy test may determine which patients with NSCLC that has spread beyond the lungs will benefit from high-dose radiation.
Read MorePosted by Andy Lundin | Sep 22, 2023 | Diagnostic Technologies |
A study demonstrated clinical utility of Predicine’s MRD liquid biopsy assay in support of Genentech’s Phase 1 Clinical Trial of Divarasib.
Read MorePosted by Chris Wolski | Sep 20, 2023 | Microscopy |
Gestalt’s Mitotic Counting algorithm was trained on over 100,000 individual mitosis and across seven scanner models.
Read MorePosted by Andy Lundin | Aug 9, 2023 | Lung Cancer |
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria.
Read MorePosted by Andy Lundin | Jul 17, 2023 | Miscellaneous |
An estimated 795,000 Americans die or are permanently disabled by diagnostic error each year, according to a new analysis of national data.
Read More